4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-17-037043
Director sold 15,000 shares at $17.01 ($255,201)
- Director acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ZASLOFF MICHAEL A Director | 2017-06-01 | Option exercise | +15,000 | $10.77 | $161,550 | 47,411 | D |
| ZASLOFF MICHAEL A Director | 2017-06-01 | Sale | −15,000 | $17.01 | $255,201 | 32,411 | D |
| Derivatives | |||||||
| ZASLOFF MICHAEL A Director | 2017-06-01 | Option exercise · Stock Option (right to buy) | −15,000 | 63,624 | D | ||
| Open-market sales · 15,000 sh · avg $17.01 · $255,201 | |||||||
Loading xslF345X03/a4.xml…